Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus

Journal of Clinical Investigation

Volumn 105, Issue 5, 2000, Pages 625-631

  Amagai, Masayuki ^a   Tsunoda, Kazuyuki ^a   Suzuki, Harumi ^a   Nishifuji, Koji ^a   Koyasu, Shigeo ^a   Nishikawa, Takeji ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; DESMOGLEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL ADHESION; CONTROLLED STUDY; HAIR LOSS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034116198     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8748     Document Type: Article

References (27)

1. McDonald, H.R. 1989. Mechanisms of immunological tolerance. Science. 246:982.
2. Goodnow, C.C. 1996. Balancing immunity and tolerance: deletion and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA. 93:2264-2271.
3. Bach, J.F., Koutouzov, S., and van Endert, P.M. 1998. Are there unique autoantigens triggering autoimmune diseases? Immunol. Rev. 164:139-155.
4. Stanley, J.R. 1998. Pemphigus. In Dermatology in general medicine. I.M. Freedberg et al., editors. McGraw-Hill, New York, NY. 654-666.
5. Amagai, M., Klaus-Kovtun, V., and Stanley, J.R. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67:869-877.
6. Stanley, J.R. 1993. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv. Immunol. 53:291-325.
7. Amagai, M. 1996. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv. Dermatol. 11:319-352.
8. Schiltz, J.R., and Michel, B. 1976. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J. Invest. Dermatol. 67:254-260.
9. Hashimoto, K., Shafran, K.M., Webber, P.S., Lazarus, G.S., and Singer, K.H. 1983. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. J. Exp. Med. 157:259-272.
10. Anhalt, G.J., Labib, R.S., Voorhees, J.J., Beals, T.F., and Diaz, L.A. 1982. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N. Engl. J. Med. 306:1189-1196.
11. Amagai, M., Karpati, S., Prussick, R., Klaus-Kovtun, V., and Stanley, J.R. 1992. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J. Clin. Invest. 90:919-926.
12. Amagai, M., Nishikawa, T., Nousari, H.C., Anhalt, G.J., and Hashimoto, T. 1998. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J. Clin. Invest. 102:775-782.
13. Koch, P.J., et al. 1997. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J. Cell Biol. 137:1091-1102.
14. Ishii, K., et al. 1997. Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus expressed recombinant desmogleins. J. Immunol. 159:2010-2017.
15. Amagai, M., Hashimoto, T., Shimizu, N., and Nishikawa, T. 1994. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J. Clin. Invest. 94:59-67.
16. Amagai, M., Hashimoto, T., Green, K.J., Shimizu, N., and Nishikawa, T. 1995. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J. Invest. Dermatol. 104:895-901.
17. + T lymphocytes: thymic selection by self antigen. J. Immunol. 157:4379-4389.
18. Amagai, M., et al. 1999. Usefulness of enzyme-linked immunosorbent assay (ELISA) using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br. J. Dermatol. 140:351-357.
19. Yuspa, S.H., Hawley-Nelson, P., Kochler, B., and Stanley, J.R. 1980. A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res. 40:4694-4703.
20. Schafer, S., Koch, P.J., and Franke, W.W. 1994. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins. Exp. Cell Res. 211:391-399.
21. Amagai, M., Koch, P.J., Nishikawa, T., and Stanley, J.R. 1996. Pemphigus vulgaris antigen (Desmoglein 3) is localized in the lower epidermis, the site of blister formation in patient. J. Invest. Dermatol. 106:351-355.
22. Koch, P.J., et al. 1998. Desmoglein 3 anchors telogen hair in the follicle. J. Cell Sci. 111:2529-2537.
23. Ding, X., et al. 1997. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J. Invest. Dermatol. 109:592-596.
24. Amagai, M., Tsunoda, K., Zillikens, D., Nagai, T., and Nishikawa, T. 1999. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J. Am. Acad. Dermatol. 40:167-170.
25. Mahoney, M.G., et al. 1999, Explanation for the clinical and microscopic localization of lesions in pemphigus foliaccus and vulgaris. J. Clin. Invest. 103:461-468.
26. Dry, F.W. 1926. The coat of the mouse (Mus musculus). J. Genet. 16:287-340.
27. Juhasz, I., Lazarus, G.S., Murphy, G.F., Shih, I.M., and Herlyn, M. 1993. Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. J. Clin. Invest. 92:2401-2407.